The Greater Pennsylvania chapter of the Alzheimer’s Association says it’s been a productive and exciting year when it comes ...

The Alzheimer’s Association reports that the disease begins as many as two decades before symptoms develop. Physically, the ...

A brain region affected very early in Alzheimer’s disease may explain why some aging people are at greater risk of financial ...

The Mercyhealth Hospital in Crystal Lake has announced it is opening a new memory and dementia clinic to focus on ...

The FDA approves an injectable Opdivo cancer drug; Axsome seeks approval for an Alzheimer's drug amid mixed results; Hain ...

Axsome Therapeutics (AXSM) stock fell 12% Monday after the company reported mixed Phase 3 results for its drug AXS-05 in the ...

Axsome Therapeutics said on Monday its experimental treatment for the Alzheimer's disease-related agitation met the main goal of a late-stage trial.

Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...

The daily medication, called hydromethylthionine mesylate (HMTM), was developed by British firm TauRX in Aberdeen ...

Officials are assessing whether hydromethylthionine mesylate (HMTM) shows sufficient promise to be given the green light for ...

Researchers from Arizona State University and Banner Alzheimer’s Institute have discovered a surprising link between a common ...